Literature DB >> 8348567

Endogenous myocardial protective (antiarrhythmic) substances.

J Parratt1.   

Abstract

Mesh:

Substances:

Year:  1993        PMID: 8348567     DOI: 10.1093/cvr/27.5.693

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  19 in total

1.  Prostaglandins and the antiarrhythmic effect of preconditioning in the isolated rat heart.

Authors:  M Arad; T Oxman; R Leor; B Rabinowitz
Journal:  Mol Cell Biochem       Date:  1996 Jul-Aug       Impact factor: 3.396

2.  Relaxin protects against myocardial injury caused by ischemia and reperfusion in rat heart.

Authors:  D Bani; E Masini; M G Bello; M Bigazzi; T B Sacchi
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

3.  The role of nitric oxide, superoxide and peroxynitrite in the anti-arrhythmic effects of preconditioning and peroxynitrite infusion in anaesthetized dogs.

Authors:  Attila Kiss; László Juhász; György Seprényi; Krisztina Kupai; József Kaszaki; Agnes Végh
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

4.  Mediation by nitric oxide of the indirect effects of adenosine on calcium current in rabbit heart pacemaker cells.

Authors:  Y Shimoni; X Han; D Severson; W R Giles
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

Review 5.  Ischaemic preconditioning of myocardium: a new paradigm for clinical cardioprotection?

Authors:  G F Baxter; D M Yellon
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

6.  Modulation of gap junctions by nitric oxide contributes to the anti-arrhythmic effect of sodium nitroprusside?

Authors:  Márton Gönczi; Rita Papp; Mária Kovács; György Seprényi; Agnes Végh
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

Review 7.  Ischemic myocardial cell protection conferred by the opening of ATP-sensitive potassium channels.

Authors:  I Cavero; Y Djellas; J M Guillon
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

8.  Feasibility of targeting ischaemia-related ventricular arrhythmias by mimicry of endogenous protection by endocannabinoids.

Authors:  Ellen Andrag; Michael J Curtis
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

9.  Relaxin-induced increased coronary flow through stimulation of nitric oxide production.

Authors:  T Bani-Sacchi; M Bigazzi; D Bani; P F Mannaioni; E Masini
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

10.  A common mechanism in the protective effects of preconditioning, cardiac pacing and physical exercise against ischemia and reperfusion-induced arrhythmias.

Authors:  Agnes Végh; James R Parratt
Journal:  Exp Clin Cardiol       Date:  2005
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.